Concepedia

Yan Tan

YT

Statistics

Publications

3

Citations

60

H-Index

3

Active since

2006

Affiliations

Fosun Pharma (China)(Current)

Yan Tan is an author at Fosun Pharma (China) specializing in pharmacology, melanoma pharmacotherapy, and checkpoint inhibitor therapy.

Publications per year

2006–2023

3

Publications

3

Liquid chromatography/tandem triple‐quadrupole mass spectrometry for determination of paclitaxel in rat tissues

Xinyong Tong, Jianping Zhou, Yan Tan · Rapid Communications in Mass Spectrometry · 2006 · 31 citations

, , +15

A first-in-human, phase 1a dose-escalation study of the selective MEK1/2 inhibitor FCN-159 in patients with advanced NRAS-mutant melanoma

Lili Mao, Jun Guo, Lingjun Zhu et al. · European Journal of Cancer · 2022 · 17 citations

, , +15

Phase 1 dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of FCN-159 in adults with neurofibromatosis type 1-related unresectable plexiform neurofibromas

Xiaojie Hu, Wenbin Li, Kang Zeng et al. · BMC Medicine · 2023 · 12 citations · Full text

, , +17

1–3 of 3